Published in J Virol on December 20, 2006
Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol (2011) 3.44
Host restriction factors blocking retroviral replication. Annu Rev Genet (2008) 2.41
Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc Natl Acad Sci U S A (2011) 1.61
Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet (2008) 1.52
p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein. Proc Natl Acad Sci U S A (2008) 1.45
Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res (2011) 1.24
Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog (2013) 1.22
The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses. J Virol (2007) 1.16
Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity. PLoS One (2012) 1.16
Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-kappaB-independent. J Biol Chem (2010) 1.13
Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNA. Nat Struct Mol Biol (2012) 1.10
Filovirus replication and transcription. Future Virol (2007) 1.09
Emerging roles for RNA degradation in viral replication and antiviral defense. Virology (2015) 1.08
Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes. BMC Evol Biol (2010) 1.08
Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection. PLoS Negl Trop Dis (2010) 1.04
MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucleic Acids Res (2013) 1.01
Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions. J Virol (2010) 1.01
Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform. Proc Natl Acad Sci U S A (2013) 0.99
The Zinc-Finger Antiviral Protein ZAP Inhibits LINE and Alu Retrotransposition. PLoS Genet (2015) 0.97
Mutagenesis analysis of the zinc-finger antiviral protein. Retrovirology (2010) 0.96
Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm. RNA Biol (2012) 0.94
DEXH-Box protein DHX30 is required for optimal function of the zinc-finger antiviral protein. Protein Cell (2010) 0.94
Rapid evolution of PARP genes suggests a broad role for ADP-ribosylation in host-virus conflicts. PLoS Genet (2014) 0.93
PARP13 regulates cellular mRNA post-transcriptionally and functions as a pro-apoptotic factor by destabilizing TRAILR4 transcript. Nat Commun (2014) 0.89
Zinc finger antiviral protein inhibits murine gammaherpesvirus 68 M2 expression and regulates viral latency in cultured cells. J Virol (2012) 0.87
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. Proc Natl Acad Sci U S A (2014) 0.87
Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein. Proc Natl Acad Sci U S A (2015) 0.86
Zinc-finger antiviral protein mediates retinoic acid inducible gene I-like receptor-independent antiviral response to murine leukemia virus. Proc Natl Acad Sci U S A (2013) 0.86
Intracellular Mono-ADP-Ribosylation in Signaling and Disease. Cells (2015) 0.85
Herpes simplex virus 1 UL41 protein abrogates the antiviral activity of hZAP by degrading its mRNA. Virol J (2015) 0.85
Analyses of SELEX-derived ZAP-binding RNA aptamers suggest that the binding specificity is determined by both structure and sequence of the RNA. Protein Cell (2010) 0.84
Zinc-finger antiviral protein inhibits XMRV infection. PLoS One (2012) 0.83
Viral Macro Domains Reverse Protein ADP-Ribosylation. J Virol (2016) 0.82
RNA Regulation by Poly(ADP-Ribose) Polymerases. Mol Cell (2015) 0.81
Glycogen synthase kinase 3β (GSK3β) modulates antiviral activity of zinc-finger antiviral protein (ZAP). J Biol Chem (2012) 0.81
ZAP inhibits murine gammaherpesvirus 68 ORF64 expression and is antagonized by RTA. J Virol (2012) 0.81
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes. Trends Cell Biol (2015) 0.80
Role of zinc-finger anti-viral protein in host defense against Sindbis virus. Int Immunol (2015) 0.80
Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer. Trends Mol Med (2015) 0.80
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses. Pharmaceuticals (Basel) (2016) 0.79
The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model. Virol J (2015) 0.77
Structural basis for lack of ADP-ribosyltransferase activity in poly(ADP-ribose) polymerase-13/zinc finger antiviral protein. J Biol Chem (2015) 0.76
Sequence variability in viral genome non-coding regions likely contribute to observed differences in viral replication amongst MARV strains. Virology (2013) 0.76
TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP). PLoS Pathog (2017) 0.76
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance. J Virol (2016) 0.76
ZAPS inhibits influenza A viral protein expression and is antagonized by the virus encoded NS1. J Virol (2016) 0.76
Nuclear matrix protein Matrin 3 is a regulator of ZAP-mediated retroviral restriction. Retrovirology (2015) 0.75
Antiviral Screening of Multiple Compounds against Ebola Virus. Viruses (2016) 0.75
ADP-ribosyltransferases and poly ADP-ribosylation. Curr Protein Pept Sci (2015) 0.75
TRIM25 Is Required for the Antiviral Activity of Zinc Finger Antiviral Protein. J Virol (2017) 0.75
Inhibition of avian tumor virus replication by CCCH-type zinc finger antiviral protein. Oncotarget (2017) 0.75
Involvement of PUF60 in Transcriptional and Post-transcriptional Regulation of Hepatitis B Virus Pregenomic RNA Expression. Sci Rep (2017) 0.75
Zinc finger-containing cellular transcription corepressor ZBTB25 promotes influenza virus RNA transcription and is a target for zinc-ejector drugs. J Virol (2017) 0.75
Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet (1977) 5.32
Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol (1999) 4.32
Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol (2006) 3.84
Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science (2002) 3.73
Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol (2006) 3.50
Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol (2003) 3.19
The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell (2002) 2.80
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol (2003) 2.25
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol (2006) 2.14
The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol (2004) 2.02
Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J (2004) 1.73
Replicon system for Lassa virus. J Virol (2004) 1.69
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61
Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. J Clin Microbiol (2001) 1.54
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol (2004) 1.43
A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology (2005) 1.40
Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30
VP40 octamers are essential for Ebola virus replication. J Virol (2005) 1.28
Development and evaluation of a fluorogenic 5'-nuclease assay to identify Marburg virus. Mol Cell Probes (2001) 1.14
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol (2002) 6.60
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med (2004) 4.89
A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2014) 4.57
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99
Insights into antiparallel microtubule crosslinking by PRC1, a conserved nonmotor microtubule binding protein. Cell (2010) 2.50
Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology (2005) 2.49
Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity (2012) 2.35
SARS--beginning to understand a new virus. Nat Rev Microbiol (2003) 2.30
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis (2009) 2.07
Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol (2011) 2.02
Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.92
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res (2003) 1.82
The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure (2003) 1.75
Ectodomain shedding of the glycoprotein GP of Ebola virus. EMBO J (2004) 1.73
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71
Replicon system for Lassa virus. J Virol (2004) 1.69
VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J Virol (2002) 1.63
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog (2010) 1.57
Phylogeny of the SARS coronavirus. Science (2003) 1.56
Epizootic emergence of Usutu virus in wild and captive birds in Germany. PLoS One (2012) 1.55
Isolation and phylogenetic analysis of Sindbis viruses from mosquitoes in Germany. J Clin Microbiol (2010) 1.55
Isolation of usutu virus in Germany. Am J Trop Med Hyg (2011) 1.55
Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54
Evidence for novel hepaciviruses in rodents. PLoS Pathog (2013) 1.54
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis (2011) 1.53
Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem (2005) 1.53
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53
Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol (2013) 1.52
Sequence analysis of L RNA of Lassa virus. Virology (2004) 1.50
Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med (2013) 1.47
Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol (2004) 1.47
Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47
Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology (2006) 1.46
VP24 of Marburg virus influences formation of infectious particles. J Virol (2005) 1.46
Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol (2004) 1.43
Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.42
Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol (2004) 1.40
Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc Natl Acad Sci U S A (2012) 1.38
Morphology of Marburg virus NP-RNA. Virology (2002) 1.38
Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc Natl Acad Sci U S A (2007) 1.37
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology (2005) 1.37
Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J Virol (2013) 1.34
Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR. J Infect Dis (2007) 1.33
First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol (2004) 1.33
Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis (2011) 1.33
Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa. PLoS One (2011) 1.32
Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain. Emerg Infect Dis (2015) 1.31
Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription. J Virol (2005) 1.30
Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30
Ebola virus transcription activator VP30 is a zinc-binding protein. J Virol (2003) 1.29
Inclusion bodies are a site of ebolavirus replication. J Virol (2012) 1.29
Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis (2005) 1.28
Role of Ebola virus VP30 in transcription reinitiation. J Virol (2008) 1.28
VP40 octamers are essential for Ebola virus replication. J Virol (2005) 1.28
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27
T cell-dependence of Lassa fever pathogenesis. PLoS Pathog (2010) 1.25
Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J Biol Chem (2003) 1.24
Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology (2005) 1.24
Isolation and phylogenetic analysis of Batai virus, Germany. Am J Trop Med Hyg (2011) 1.24
An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome. J Virol (2009) 1.22
Budding of Marburgvirus is associated with filopodia. Cell Microbiol (2006) 1.22
Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein. J Virol (2010) 1.20
Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol (2013) 1.19
Dengue and Chikungunya virus co-infection in a German traveller. J Clin Virol (2009) 1.19
Acute Zika virus infection after travel to Malaysian Borneo, September 2014. Emerg Infect Dis (2015) 1.18
Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia (2007) 1.16
Tacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Negl Trop Dis (2011) 1.16
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog (2012) 1.16
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol (2005) 1.15
Current molecular epidemiology of Lassa virus in Nigeria. J Clin Microbiol (2010) 1.15
Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol (2007) 1.13
Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med (2003) 1.13
Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. J Virol (2010) 1.12
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu). J Infect Dis (2013) 1.12
Establishment and application of an infectious virus-like particle system for Marburg virus. J Gen Virol (2010) 1.11
Lassa fever, Nigeria, 2005-2008. Emerg Infect Dis (2010) 1.10
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol (2013) 1.10
Sequence and phylogenetic analysis of hepatitis B virus genotype G isolated in Germany. Virus Genes (2002) 1.09